Thu, Nov 12, 2026 - Page 21
13819 indexed SquawkNews stories from this UTC day. Showing 2401-2520.
L
WD-40 to Attend Morgan Stanley Consumer and Retail Conference
WD-40 Company says it will participate in the conference on the 1st; the body does not specify a month.
EQUITY | Nov 12, 2026, 09:09 PM UTC
L
WD-40 to Participate in Morgan Stanley Consumer and Retail Conference
WD-40 will attend the Morgan Stanley Global Consumer & Retail Conference.
EQUITY | Nov 12, 2026, 09:09 PM UTC
L
BRIEF-Cyrela Q3 Net Profit 481 Million Reais Vs IBES Estimate 517 Million Reais
BRIEF-Cyrela Q3 Net Profit 481 Million Reais Vs IBES Estimate 517 Million Reais Nov 12 (Reuters) - C
EARNINGS | Nov 12, 2026, 09:09 PM UTC
H
Vinci Compass: Q3 Earnings Snapshot
LEBLON-RIO DE JANEIRO, Brazil (AP) — LEBLON-RIO DE JANEIRO, Brazil (AP) — Vinci Compass Investments
EARNINGS | Nov 12, 2026, 09:09 PM UTC
L
BRIEF-Peraso Q3 Adjusted Net Income USD -2.454 Million
Nov 12 (Reuters) - Peraso Q3 net income USD -2.658 million.
FX | Nov 12, 2026, 09:09 PM UTC
L
IZEA Worldwide Q3 revenue falls 23% on SMB decline
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EARNINGS | Nov 12, 2026, 09:09 PM UTC
L
dLocal Reports Third Quarter 2026 Financial Results
TPV reached US$18 billion (+77% year-over-year), marking the 8th consecutive quarter of 50%+ year-ov
EQUITY | Nov 12, 2026, 09:09 PM UTC
H
$CSCO Cisco Q1 Earnings
Adjusted EPS $1.40, est. $1.32 Revenue $18.50B, est. $18.13B Adjusted gross margin 65.6%, est. 65.6% Product revenue $14.67B, est. $14.29B Service revenue $3.85B, est. $3.83B Remaining performance obligations $46.17B, es
EARNINGS | Nov 12, 2026, 09:09 PM UTC
L
dLocal Reports Third Quarter 2026 Financial Results
dLocal Reports Third Quarter 2026 Financial Results TPV reached US$18 billion (+77% year-over-year),
EQUITY | Nov 12, 2026, 09:09 PM UTC
L
DLOCAL Q3 GROSS MARGIN 33%
DLOCAL Q3 GROSS MARGIN 33%
EQUITY | Nov 12, 2026, 09:09 PM UTC
L
DLOCAL Q3 REVENUE USD 398 MILLION VS. IBES ESTIMATE USD 412 MILLION
DLOCAL Q3 REVENUE USD 398 MILLION VS. IBES ESTIMATE USD 412 MILLION
EARNINGS | Nov 12, 2026, 09:09 PM UTC
L
DLOCAL REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
DLOCAL REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 09:09 PM UTC
L
BRIEF-Peraso Q3 Adjusted Net Income USD -2.454 Million
BRIEF-Peraso Q3 Adjusted Net Income USD -2.454 Million Nov 12 (Reuters) - Peraso Q3 net income USD
FX | Nov 12, 2026, 09:09 PM UTC
L
DLOCAL Q3 GROSS PROFIT USD 132 MILLION
DLOCAL Q3 GROSS PROFIT USD 132 MILLION
EARNINGS | Nov 12, 2026, 09:09 PM UTC
M
IZEA Worldwide Q3 Revenue Falls 23%
IZEA Worldwide reported a 23% decline in Q3 revenue, citing a decline in SMB revenue.
EQUITY | Nov 12, 2026, 09:09 PM UTC
L
Kodiak Sciences Q3 net loss widens as R&D expenses rise
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
Kodiak Sciences Q3 net loss widens as R&D expenses rise
Kodiak Sciences Q3 net loss widens as R&D expenses rise Overview US retina biotech's Q3 net loss wid
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
4D Molecular Therapeutics Q3 2026 net loss widens 37% to $78.06 million
4D Molecular Therapeutics Q3 2026 net loss widens 37% to $78.06 million 4D Molecular Therapeutic
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
SELLAS Life Sciences 3Q Loss/Shr 5c >SLS
SELLAS Life Sciences 3Q Loss/Shr 5c >SLS
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
Rocket Pharmaceuticals Q3 net loss narrows as R&D costs fall
Rocket Pharmaceuticals Q3 net loss narrows as R&D costs fall Overview US biotechnology firm's Q3 net
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
Vuzix Q3 2026 net loss widens 14% to $8.39 million; total revenues fall 38% to $714,000
Vuzix Q3 2026 net loss widens 14% to $8.39 million; total revenues fall 38% to $714,000 Vuzix’s
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
SKYX Q3 2026 gross profit rises 11% quarter-over-quarter to $8.1 million; revenue climbs 7% year-over-year to $25.7 million
SKYX Q3 2026 gross profit rises 11% quarter-over-quarter to $8.1 million; revenue climbs 7% year-ove
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
Knightscope Q3 net loss widens 24% to $11.8 million; revenue more than doubles to $8.7 million
Knightscope Q3 net loss widens 24% to $11.8 million; revenue more than doubles to $8.7 million K
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
Kalshi Ends Donald Trump Jr.’s Advisory Contract
Kalshi ended Donald Trump Jr.’s advisory contract over 1789 Capital’s investment in Polymarket.
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
FLOWERS FOODS OUTLOOK FY ADJUSTED EPS USD 0.63-0.68
FLOWERS FOODS OUTLOOK FY ADJUSTED EPS USD 0.63-0.68
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
SENSUS HEALTHCARE Q3 EPS USD -0.09
SENSUS HEALTHCARE Q3 EPS USD -0.09
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
Rocket Pharmaceuticals Q3 net loss narrows as R&D costs fall
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
Tesla Shares Rise as Bloomberg Reports Progress in SpaceX Merger Talks
Tesla shares rose as much as 1.9% to $398.35 Thursday after reports that merger negotiations with SpaceX are progressing. The stock remains down 11% year to date.
MNA | Nov 12, 2026, 09:08 PM UTC
M
Cerebras shares rise 6% in extended trading after quarterly report
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
PERASO Q3 ADJUSTED NET INCOME USD -2.454 MILLION
PERASO Q3 ADJUSTED NET INCOME USD -2.454 MILLION
FX | Nov 12, 2026, 09:08 PM UTC
L
PERASO Q3 REVENUE USD 284 THOUSAND
PERASO Q3 REVENUE USD 284 THOUSAND
EARNINGS | Nov 12, 2026, 09:08 PM UTC
M
Peraso Announces Third-Quarter 2026 Results
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
VIRGIN GALACTIC HOLDINGS SHARES RISE 2.6% TO $2.74 AFTER THE BELL FOLLOWING RESULTS
VIRGIN GALACTIC HOLDINGS SHARES RISE 2.6% TO $2.74 AFTER THE BELL FOLLOWING RESULTS
EARNINGS | Nov 12, 2026, 09:08 PM UTC
M
Cerebras Q3 Revenue Climbs 55% to $210.8 Million; Gross Margin Rises
Cerebras reported Q3 2026 revenue of $210.8 million, up 55% year over year, while GAAP gross margin rose sequentially to 20%.
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
PERASO Q3 NET INCOME USD -2.658 MILLION
PERASO Q3 NET INCOME USD -2.658 MILLION
FX | Nov 12, 2026, 09:08 PM UTC
L
Buda Juice Q3 net income falls year over year to $866,000; Q3 revenue rises 64% year over year to $5.21 million
Buda Juice Q3 net income falls year over year to $866,000; Q3 revenue rises 64% year over year to $5
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
GCT Semiconductor Q3 2026 net loss narrows 47% year over year to $7.39 million
GCT Semiconductor Q3 2026 net loss narrows 47% year over year to $7.39 million GCT Semiconductor
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
FLOWERS FOODS OUTLOOK FY REVENUE USD 5,016-5,063 MILLION
FLOWERS FOODS OUTLOOK FY REVENUE USD 5,016-5,063 MILLION
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
CYRELA Q3 NET REVENUE 2.4 BLN REAIS VS IBES ESTIMATE 2.6 BLN REAIS
CYRELA Q3 NET REVENUE 2.4 BLN REAIS VS IBES ESTIMATE 2.6 BLN REAIS
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
Brazil's Vinci Compass Q3 net income hits record on Galeão gain
Brazil's Vinci Compass Q3 net income hits record on Galeão gain Overview Brazil alternative asset ma
EQUITY | Nov 12, 2026, 09:08 PM UTC
H
Talphera: Q3 Earnings Snapshot
SAN MATEO, Calif. (AP) — SAN MATEO, Calif.
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
BRIEF-StoneCo Q3 Recurring Adjusted Net Profit 542 Million Reais Vs IBES Estimate 613 Million Reais
BRIEF-StoneCo Q3 Recurring Adjusted Net Profit 542 Million Reais Vs IBES Estimate 613 Million Reais
EARNINGS | Nov 12, 2026, 09:08 PM UTC
H
Curis: Q3 Earnings Snapshot
LEXINGTON, Mass. (AP) — LEXINGTON, Mass.
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
TENON MEDICAL Q3 EPS USD -5.39
TENON MEDICAL Q3 EPS USD -5.39
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
ADARx Pharmaceuticals 3Q Rev $2.22M >ADRX
ADARx Pharmaceuticals 3Q Rev $2.22M >ADRX
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
CYRELA Q3 NET PROFIT 481 MLN REAIS VS IBES ESTIMATE 517 MLN REAIS
CYRELA Q3 NET PROFIT 481 MLN REAIS VS IBES ESTIMATE 517 MLN REAIS
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
Intrusion Q3 net loss widens 47% year over year to $3.08 million
Intrusion Q3 net loss widens 47% year over year to $3.08 million Intrusion's third-quarter 2026
EQUITY | Nov 12, 2026, 09:08 PM UTC
H
$AMAT Applied Materials Q4 Earnings
Adjusted EPS $4.16, est. $4.06 Net sales $10.41B, est. $10.27B Semiconductor Systems net sales $8.00B, est. $7.94B Sees Q1 net sales $10.60B to $11.60B, est. $10.87B
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
ADARx Pharmaceuticals 3Q Loss/Shr $1.74 >ADRX
ADARx Pharmaceuticals 3Q Loss/Shr $1.74 >ADRX
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results
FORTIFY, a Phase 1b indication expansion trial of PLN-101095, continues strong enrollment Pliant’s p
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
Cisco Q1 Operating Margin 30.2%
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
Gaxos Reports Third-Quarter Revenue Growth of 14.5% Sequentially and 464.9% Year over Year
Advertising and marketing expense decreases 16.7% sequentially as revenue per dollar of advertising
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
Park Dental Partners Announces Third Quarter 2026 Results
MINNEAPOLIS, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc.
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
AmpliTech Group Reports Q3 2026 Revenue of $6.58 Million, Up 8.0% Year-over-Year, and 41.1% Nine-Month Gross Profit Growth
HAUPPAUGE, N.Y., Nov. 12, 2026 (GLOBE NEWSWIRE) -- AmpliTech Group, Inc.
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
Crown Crafts Announces Financial Results for Second Quarter Fiscal 2027
GONZALES, La., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Crown Crafts, Inc.
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
Candel Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
The Company is in ongoing dialogue with the FDA regarding the submission of a Biologics License Appl
REGULATION | Nov 12, 2026, 09:08 PM UTC
L
INNOVATE Corp. Announces Third Quarter 2026 Results
Infrastructure: INNOVATE completes sale of DBM Global to IES Holdings - Life Sciences: MediBeacon
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
Rekor Systems Reports Third Quarter 2026 Financial Results
COLUMBIA, Md., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Rekor Systems, Inc.
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
Andersen Group Q3 net income drops 39% to $67.97 million; Q3 revenue rises 19% to $337.32 million
Andersen Group Q3 net income drops 39% to $67.97 million; Q3 revenue rises 19% to $337.32 million
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
Accelevation Holdings Corp. Reports Strong Third Quarter 2026 with Revenue Growth of 66%, Bookings Growth of over 350%, and Robust Cash Gene
Third Quarter 2026 Business Highlights Revenue grew 65.9% year over year to $202.2 million. Bookings
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
Merlin, Inc. Reports Third Quarter 2026 Results
BOSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Merlin, Inc.
EQUITY | Nov 12, 2026, 09:08 PM UTC
M
Cisco Reports 1Q Deferred Revenue of $30.1 Billion
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
VirTra Reports Third Quarter and Nine Months 2026 Financial Results
CHANDLER, Ariz., Nov. 12, 2026 (GLOBE NEWSWIRE) -- VirTra, Inc.
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2026
PORTLAND, Maine, Nov. 12, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” o
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
PEDEVCO Reports Third Quarter 2026 Results
HOUSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) -- PEDEVCO Corp.
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
Scribe Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
Listed on the Nasdaq Global Market under the ticker symbol “SCTX,” and raised capital to fund the in
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
CapsoVision Reports Third Quarter 2026 Financial Results
SARATOGA, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc.
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
LifeMD Reports Third Quarter 2026 Results
Third quarter 2026 revenue of $44.6 million; adjusted EBITDA loss of approximately $0.4 million, wit
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
Dragonfly Energy Reports Third Quarter 2026 Results
Heavy-Duty Trucking Revenue More Than Doubled Sequentially as Fleet Adoption Accelerates Trucking Mo
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
CYRELA Q3 NET REVENUE 2.4 BLN REAIS VS IBES ESTIMATE 2.6 BLN REAIS
CYRELA Q3 NET REVENUE 2.4 BLN REAIS VS IBES ESTIMATE 2.6 BLN REAIS
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
BRIEF-Pliant Therapeutics Q3 Net Income USD -24.377 Million
BRIEF-Pliant Therapeutics Q3 Net Income USD -24.377 Million Nov 12 (Reuters) - Pliant Therapeutics Q
FX | Nov 12, 2026, 09:08 PM UTC
L
BRIEF-Relmada Therapeutics Q3 EPS USD -0.12
BRIEF-Relmada Therapeutics Q3 EPS USD -0.12 Nov 12 (Reuters) - Relmada Therapeutics Q3 net income US
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
Birchtech Reports Third Quarter 2026 Financial Results
Third Quarter 2026 Product Revenues Grew 15.7% Year-over-Year to $5.5 Million; Appellee Brief Filed
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
BRIEF-LifeMD Inc Q3 Gross Margin 82%
BRIEF-LifeMD Inc Q3 Gross Margin 82% Nov 12 (Reuters) - LifeMD Inc Q3 revenue USD 44.6 million vs. I
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
Relmada Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
NDV-01 CMC program on track to submit the IND by year-end 2026, with initiation of the registrationa
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
BRIEF-OpenWorld, Inc. Q3 Gross Margin 80%
BRIEF-OpenWorld, Inc. Q3 Gross Margin 80% Nov 12 (Reuters) - OpenWorld, Inc.
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
VIRGIN GALACTIC OUTLOOK Q4 FREE CASH FLOW USD -90 TO -80 MILLION
VIRGIN GALACTIC OUTLOOK Q4 FREE CASH FLOW USD -90 TO -80 MILLION
FX | Nov 12, 2026, 09:08 PM UTC
L
BRIEF-VirTra Q3 EPS USD 0.19
BRIEF-VirTra Q3 EPS USD 0.19 Nov 12 (Reuters) - VirTra Q3 revenue USD 7.6 million. Q3 net income USD
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
WidePoint Reports Third Quarter 2026 Financial Results
FAIRFAX, Va., Nov. 12, 2026 (GLOBE NEWSWIRE) -- WidePoint Corporation (NYSE American: WYY), a leadin
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
BRIEF-Candel Therapeutics Q3 Net Income USD -21.873 Million
BRIEF-Candel Therapeutics Q3 Net Income USD -21.873 Million Nov 12 (Reuters) - Candel Therapeutics Q
FX | Nov 12, 2026, 09:08 PM UTC
L
Streamex Reports Third Quarter 2026 Results
240 net new ounces behind GLDY, up from 15 in Q2; Cask Foundation begins liquidity bootstrapping for
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
BRIEF-Crown Crafts Q2 EPS USD 0.12
BRIEF-Crown Crafts Q2 EPS USD 0.12 Nov 12 (Reuters) - Crown Crafts Q2 revenue USD 19.028 million. Q2
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
BRIEF-4D Molecular Therapeutics Q3 Net Income USD -78.056 Million Vs. IBES Estimate USD -74.2 Million
BRIEF-4D Molecular Therapeutics Q3 Net Income USD -78.056 Million Vs. IBES Estimate USD -74.2 Millio
FX | Nov 12, 2026, 09:08 PM UTC
L
LIFTOFF MOBILE OUTLOOK FY REV $907 MLN TO\t$912 MLN
LIFTOFF MOBILE OUTLOOK FY REV $907 MLN TO\t$912 MLN
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
BRIEF-System1 Inc. Q3 Revenue USD 26 Million
BRIEF-System1 Inc. Q3 Revenue USD 26 Million Nov 12 (Reuters) - System1 Inc.
EARNINGS | Nov 12, 2026, 09:08 PM UTC
M
LifeMD Reports Third-Quarter 2026 Results
LifeMD reported third-quarter 2026 revenue of $44.6 million. The supplied text cuts off after “adjusted EBIT.”
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
Cibus Reports Third Quarter Financial Results and Provides Business Update
Rice herbicide-tolerance traits performed well in Latin American field trials and are now being test
EQUITY | Nov 12, 2026, 09:08 PM UTC
L
BRIEF-Fluent Q3 Net Income USD -3.125 Million
BRIEF-Fluent Q3 Net Income USD -3.125 Million Nov 12 (Reuters) - Fluent Q3 revenue USD 53.642 millio
EARNINGS | Nov 12, 2026, 09:08 PM UTC
L
BRIEF-SoundThinking Q3 Net Income USD -8.472 Million
BRIEF-SoundThinking Q3 Net Income USD -8.472 Million Nov 12 (Reuters) - SoundThinking Q3 adjusted EB
FX | Nov 12, 2026, 09:08 PM UTC
L
BRIEF-SELLAS Life Sciences Q3 Net Income USD -10.091 Million
BRIEF-SELLAS Life Sciences Q3 Net Income USD -10.091 Million Nov 12 (Reuters) - SELLAS Life Sciences
FX | Nov 12, 2026, 09:08 PM UTC
M
Cisco reports first-quarter adjusted EPS of $1.40
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
BRIEF-Flowers Foods Q3 Adjusted EPS USD 0.1 Vs. IBES Estimate USD 0.15
BRIEF-Flowers Foods Q3 Adjusted EPS USD 0.1 Vs. IBES Estimate USD 0.15 Nov 12 (Reuters) - Flowers Fo
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
BRIEF-NeuroPace, Inc. Q3 EPS USD -0.1
BRIEF-NeuroPace, Inc. Q3 EPS USD -0.1 Nov 12 (Reuters) - NeuroPace, Inc.
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
BRIEF-TransAct Technologies Q3 EPS USD -0.04
BRIEF-TransAct Technologies Q3 EPS USD -0.04 Nov 12 (Reuters) - TransAct Technologies Q3 adjusted EB
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
NorthStar Earth & Space Reports Third Quarter 2026 Results
Revenue of $17.2 million, up $15.8 million from Q3 2025 Operating income of $10.4 million, up $13.4
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
BRIEF-Solesence Inc Q3 Gross Profit USD 7.928 Million
BRIEF-Solesence Inc Q3 Gross Profit USD 7.928 Million Nov 12 (Reuters) - Solesence Inc Q3 pretax pro
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
BRIEF-Intellicheck Q3 Revenue USD 5.739 Million
BRIEF-Intellicheck Q3 Revenue USD 5.739 Million Nov 12 (Reuters) - Intellicheck Q3 operating expense
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
BRIEF-Sensus Healthcare Q3 Net Income USD -1.493 Million
BRIEF-Sensus Healthcare Q3 Net Income USD -1.493 Million Nov 12 (Reuters) - Sensus Healthcare Q3 bas
FX | Nov 12, 2026, 09:07 PM UTC
L
BRIEF-Spruce Power Q3 Revenue USD 29.693 Million
BRIEF-Spruce Power Q3 Revenue USD 29.693 Million Nov 12 (Reuters) - Spruce Power Q3 income from oper
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
Dillard’s, Inc. Reports Third Quarter and Year-to-Date Results
LITTLE ROCK, Ark., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Dillard’s, Inc.
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
BRIEF-Arcadia Biosciences Q3 Net Income USD 1.755 Million
BRIEF-Arcadia Biosciences Q3 Net Income USD 1.755 Million Nov 12 (Reuters) - Arcadia Biosciences Q3
FX | Nov 12, 2026, 09:07 PM UTC
L
BRIEF-Newsmax Inc Q3 Revenue USD 16 Million
BRIEF-Newsmax Inc Q3 Revenue USD 16 Million Nov 12 (Reuters) - Newsmax Inc Q3 net income USD 15.2 mi
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
BRIEF-Codexis Q3 Basic EPS USD -0.08
BRIEF-Codexis Q3 Basic EPS USD -0.08 Nov 12 (Reuters) - Codexis Q3 net income USD -8.128 million. Q3
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
BRIEF-HireQuest Q3 Revenue USD 8.8 Million
BRIEF-HireQuest Q3 Revenue USD 8.8 Million Nov 12 (Reuters) - HireQuest Q3 adjusted EBITDA USD 4.5 m
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
BRIEF-Digimarc Q3 Revenue USD 6.446 Million
BRIEF-Digimarc Q3 Revenue USD 6.446 Million Nov 12 (Reuters) - Digimarc Q3 operating income USD -8.0
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
BRIEF-ImmuCell Corporation Q3 EPS USD 0.1
BRIEF-ImmuCell Corporation Q3 EPS USD 0.1 Nov 12 (Reuters) - ImmuCell Corporation Q3 pretax profit U
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
BRIEF-Vuzix Q3 Net Income USD -8.386 Million
BRIEF-Vuzix Q3 Net Income USD -8.386 Million Nov 12 (Reuters) - Vuzix Q3 operating income USD -8.477
FX | Nov 12, 2026, 09:07 PM UTC
L
BRIEF-Lineage Cell Therapeutics Q3 Net Income USD 4.23 Million
BRIEF-Lineage Cell Therapeutics Q3 Net Income USD 4.23 Million Nov 12 (Reuters) - Lineage Cell Thera
FX | Nov 12, 2026, 09:07 PM UTC
L
BRIEF-Virgin Galactic Q3 Revenue USD 427 Thousand Vs. IBES Estimate USD 400 Thousand
BRIEF-Virgin Galactic Q3 Revenue USD 427 Thousand Vs. IBES Estimate USD 400 Thousand Nov 12 (Reuters
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
Gaxos Reports Third-Quarter Revenue Growth of 14.5% Sequentially and 464.9% Year over Year
Gaxos Reports Third-Quarter Revenue Growth of 14.5% Sequentially and 464.9% Year over Year Advertisi
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
JAB Acquisition Holds Extraordinary Shareholder Meeting
JAB Acquisition held an extraordinary shareholder meeting; shareholders approved a proposal, but the available report is truncated before identifying it.
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
GAXOS REPORTS THIRD-QUARTER REVENUE GROWTH OF 14.5% SEQUENTIALLY AND 464.9% YEAR OVER YEAR
GAXOS REPORTS THIRD-QUARTER REVENUE GROWTH OF 14.5% SEQUENTIALLY AND 464.9% YEAR OVER YEAR
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
Alumis Reports Third Quarter 2026 Financial Results and Highlights Recent Business Updates
New Phase 3 data demonstrated rapid and durable improvements in plaque psoriasis burden, adding to
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
BRIEF-Tenon Medical Q3 Net Income USD -6.639 Million
BRIEF-Tenon Medical Q3 Net Income USD -6.639 Million Nov 12 (Reuters) - Tenon Medical Q3 revenue USD
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
Gaxos Reports Third-Quarter Revenue Growth of 14.5% Sequentially and 464.9% Year over Year
Gaxos Reports Third-Quarter Revenue Growth of 14.5% Sequentially and 464.9% Year over Year Advertisi
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
NORTHSTAR EARTH & SPACE REPORTS THIRD QUARTER 2026 RESULTS
NORTHSTAR EARTH & SPACE REPORTS THIRD QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Brazil's Vinci Compass Q3 net income hits record on Galeão gain
OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Solésence Reports Record Third Quarter 2026 Financial Results
Solésence Reports Record Third Quarter 2026 Financial Results Third quarter revenue increases 38% ye
CRYPTO | Nov 12, 2026, 09:07 PM UTC
L
Azora Therapeutics Reports 2026 Third Quarter Financial Results and Provides Business Update
Azora Therapeutics commenced trading on Nasdaq as “AZR” New executive team and Board of Directors ap
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
OpenWorld, Inc. Reports 2026 Third Quarter Results; First Quarterly Results as a Nasdaq-Listed Company
OpenWorld, Inc. Reports 2026 Third Quarter Results; First Quarterly Results as a Nasdaq-Listed Compa
EQUITY | Nov 12, 2026, 09:07 PM UTC